Development of innovative biomaterials and devices for the treatment of cardiovascular diseases

Y Wang, G Li, L Yang, R Luo, G Guo - Advanced Materials, 2022 - Wiley Online Library
Cardiovascular diseases have become the leading cause of death worldwide. The
increasing burden of cardiovascular diseases has become a major public health problem …

Coronary in-stent restenosis: predictors and treatment

H Ullrich, M Olschewski, T Muenzel… - Deutsches Ärzteblatt …, 2021 - pmc.ncbi.nlm.nih.gov
Background Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR)
may still occur in as many as 2–10% of percutaneous coronary interventions (PCI) in certain …

The mechanisms of restenosis and relevance to next generation stent design

J Clare, J Ganly, CA Bursill, H Sumer, P Kingshott… - Biomolecules, 2022 - mdpi.com
Stents are lifesaving mechanical devices that re-establish essential blood flow to the
coronary circulation after significant vessel occlusion due to coronary vessel disease or …

[HTML][HTML] Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing

L Wen, H Qiu, S Li, Y Huang, Q Tu, N Lyu, X Mou… - Acta Biomaterialia, 2024 - Elsevier
Endovascular stenting is a safer alternative to open surgery for use in treating cerebral
arterial stenosis and significantly reduces the recurrence of ischemic stroke, but the widely …

Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis: Impact of neoatherosclerosis in ISR on clinical outcome

D Nakamura, T Dohi, T Ishihara, A Kikuchi… - …, 2021 - pmc.ncbi.nlm.nih.gov
Background In-stent restenosis (ISR), especially for neoatherosclerosis, is still a major
problem of percutaneous coronary intervention (PCI) even in the drug-eluting stent (DES) …

[HTML][HTML] Circulating biomarkers reflecting destabilization mechanisms of coronary artery plaques: are we looking for the impossible?

M Kumric, JA Borovac, D Martinovic, T Ticinovic Kurir… - Biomolecules, 2021 - mdpi.com
Despite significant strides to mitigate the complications of acute coronary syndrome (ACS),
this clinical entity still represents a major global health burden. It has so far been well …

Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis

ZF Lu, WH Yin, UJ Schoepf, S Abrol, JW Ma, L Zhao… - European …, 2024 - Springer
Objectives As a novel imaging marker, pericoronary fat attenuation index (FAI) reflects the
local coronary inflammation which is one of the major mechanisms for in-stent restenosis …

In-stent restenosis.

K Kawai, R Virmani, AV Finn - Interventional Cardiology Clinics, 2022 - europepmc.org
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary
intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal …

Phase-transited lysozyme nanofilm with co-immobilized copper ion and heparin as cardiovascular stent multifunctional coating

L Xu, C He, S Yang, Y Zhu, P Wang, S Wu… - Colloids and Surfaces B …, 2023 - Elsevier
Cardiovascular metal stents have shown potential in the treatment of coronary artery
disease using percutaneous coronary intervention. However, thrombosis, endothelialization …

Restoring endothelial function: shedding light on cardiovascular stent development

W Liu, X Wang, Y Feng - Biomaterials Science, 2023 - pubs.rsc.org
Complete endothelialization is highly important for maintaining long-term patency and
avoiding subsequent complications in implanting cardiovascular stents. It not only refers to …